BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 20, 2005
View Archived Issues
New oxazolinone-based uPA inhibitor with potential in cancer therapy
Read More
New phase III data on the efficacy of fesoterodine in OAB
Read More
First results on the efficacy and safety of EG-005 in lipodystrophy
Read More
Good safety profile reported for CTLA4-Ig in multiple sclerosis
Read More
AVP-923 improves pseudobulbar affect in patients with MS
Read More
Withdrawal of European marketing authorizations for Venvia/Nyracta
Read More
Kentera begins European roll-out
Read More
Enrollment begins in phase III alfimeprase study for acute PAO
Read More
AVI BioPharma presents positive data from studies on NeuGene antisense technology
Read More
Roche will not pursue MEM-1414, MEM-1917 in Memory collaboration
Read More
Ranexa meets primary endpoint in ERICA study
Read More
Novel voltage-sensitive sodium channel blockers with activity against human prostate cancer
Read More
Clavis Pharma presents promising oral alternative to gemcitabine
Read More
Cellegy submits Cellegesic written response
Read More
Novel G-quadruplex DNA motif-targeting agent nearing human testing
Read More
AP-23573 receives fast track designation for soft tissue and bone sarcomas
Read More
Early clinical results for Clavis Pharma's lead development candidate
Read More
New European approval for InductOs
Read More
Antiviral effects of a novel nonimmunosuppressive ciclosporin analogue
Read More
Chugai, Mitsui and CIEA create Forerunner Pharma Research
Read More
Intendis opens new Japanese subsidiary
Read More
Inflazyme charts progress from preclinical company
Read More
Effects of ospemifene and raloxifene compared in postmenopausal women
Read More
Abciximab evaluated in acute ischemic stroke
Read More
JSW-Research claims new agents for CNS degenerative disorders
Read More
Neurocrine reports new agents for gynecological disorders
Read More
New antismoking therapy developed by Pfizer
Read More